As new standards of cancer care are being implemented nationwide and our health care system is changing, Triage Cancer hopes to be in the forefront of educating health care providers, and the cancer community in general, so that they can best utilize the valuable tools and resources that are available for their constituencies.
Triage Cancer collaborates with experts in the areas of medicine, mental health, nursing, social work, patient navigation, nutrition, oncofertility, law, employment, education, financial management, insurance, relationships, sexuality and intimacy, pain and palliative care, advocacy, and other areas of cancer survivorship.
The Triage Cancer Scientific Advisory Council provides guidance on substantive areas of cancer survivorship so that we may best serve the cancer community.
Medical oncologist Ardaman Shergill, MD, specializes in providing comprehensive care to patients with all stages of gastrointestinal cancers, with expertise in treating pancreatobiliary and lower gastrointestinal cancers (appendix, colon, rectum, anal).
Her research focuses on clinical investigations of targeted therapies for gastrointestinal cancers, especially treatments aimed at the KRAS pathway found in some gastrointestinal cancers. Dr. Shergill is developing clinical trials that use novel therapies to advance clinical care. She serves as executive officer and part of the leadership team for the gastrointestinal cancers committee at the Alliance for Clinical Trials in Oncology, a National Cancer Institute funded oncology research organization.
Dr. Shergill has published research in several peer-reviewed journals, including Oncology, Annals of Surgical Oncology, Journal of ImmunoTherapy of Cancer, Journal of Gastrointestinal Surgery, Journal of Gastrointestinal Oncology and Cancer Informatics.